Boryung Pharmaceutical Co., Ltd

This early-phase trial tested a new drug called BR101801 in 26 adults with advanced blood cancers like lymphoma and leukemia that had not responded to other treatments. The main goals were to find a safe dose and check for side effects. The study was completed, but results are no…

This study watched 1,839 adults with high cholesterol who were given a new combination of two medicines (atorvastatin and ezetimibe) for 24 weeks. Researchers wanted to see how well the combo lowered bad cholesterol and if it was safe in everyday use. The goal was to understand h…

This study tested whether taking two experimental drugs together (BR1018B and BR1018C) can safely lower both blood pressure and LDL cholesterol in people with essential hypertension and primary hypercholesterolemia. A total of 156 adults participated. The main goals were to see h…

This study observed over 6,400 adults undergoing surgery to see how doctors prescribe sugammadex, a drug that reverses muscle relaxants. Researchers tracked dosing, re-administration rates, and side effects within 24 hours. No extra tests or treatments were given—just routine car…

This study observed 799 adults with advanced or metastatic pancreatic cancer in Korea to see which chemotherapy treatments doctors actually use and why. Researchers tracked treatment choices, survival times, and quality of life. The goal was to understand real-world practices, no…

This early-stage study tested a new drug called BR1018, along with two other drugs (BR1018A and BR1018B), in 60 healthy adults. The goal was to see how the drugs move through the body and to check for any safety issues. The study is now complete and helps researchers understand h…